Moderna says COVID-19 vaccine 96 percent effective in teens

Moderna on Thursday released the results of its COVID-19 vaccine trials for those aged 12 to 17, reporting it 96 percent effective against the virus. The vaccine manufacturer said its trial, involving 3,235 participants, recorded 12 COVID-…